Arghya Paik

About

Postgraduate Master's of Pharmacy in Pharmaceutical Chemistry at Acharya & B.M. Reddy College of Pharmacy, affiliated with the Rajiv Gandhi University of Health Sciences, Bengaluru, India. My present research work focuses on the “Exploration of Quinazoline analogues for Metastatic Melanoma.” I obtained my B. Pharm degree from the same institute. My primary research interests include Computer-Aided Drug Design (CADD), organic synthesis, and the evaluation of cellular biological activities of novel entities as potential anticancer agents.
Additionally, I have a strong understanding of MS Office tools (Word, PowerPoint, and Excel) for effective data management and polished presentations. I am also knowledgeable in applying AI-based tools in a professional setting. I am dedicated to transforming pharmaceutical research and development with innovative solutions that combine scientific insight and digital expertise.

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• “Benzimidazole Derived Non-CDN STING Agonists: Mechanisms, SAR Evolution, and Therapeutic Potential - A Comprehensive Review”
  Bioorganic Chemistry 2026 DOI: 10.1016/j.bioorg.2026.109704
  +Save
• Medicinal chemistry perspective of chalcone derivatives as anticancer agents: synthetic strategy, biological activity, and structure-activity relationship
  Aryadipto Dasgupta, R. Rajesh, Pronoy Kanti Das +3 more
  Molecular Diversity 2026 DOI: 10.1007/s11030-025-11434-w
  +Save
• Medicinal chemistry perspective on quinazoline derivatives: Sustainable synthetic routes, anticancer evaluation, and SAR analysis
  Sudarshini Dutta, R. Rajesh, Gurubasavaraja Swamy Purawarga Matada +5 more
  European Journal of Medicinal Chemistry 2026 DOI: 10.1016/j.ejmech.2025.118538
  +Save
• "Emerging precision drug delivery systems for controlled activation of the cGAS-STING pathway in Cancer, infection, and autoimmune disorders".
  International immunopharmacology 2025 DOI: 10.1016/j.intimp.2025.116052
  +Save
• Recent Advances in Quinoline Derivatives: Biological and Medicinal Insights
  ChemistrySelect 2025 DOI: 10.1002/slct.202503934
  +Save
• Unravelling Immunity: Understanding Inflammatory Pathways as Key Players in Immune Response and Disease Progression
  Current Molecular Biology Reports 2025 DOI: 10.1007/s40610-025-00167-2
  +Save
• BRAF inhibitors in Melanoma: Structural Insights, Therapeutic Resistance, and Biological Evaluation of Quinazoline Derivatives
  Arghya Paik, Gurubasavaraja Swamy Purawarga Matada, Abhishek Ghara +3 more
  European Journal of Medicinal Chemistry 2025 DOI: 10.1016/j.ejmech.2025.117866
  +Save